Status:
RECRUITING
Integration of Remote Monitoring in the Management of Chronic Immunosuppressive Therapy
Lead Sponsor:
University Of Perugia
Conditions:
Rheumatoid Arthritis
Psoriatic Arthritis
Eligibility:
All Genders
Phase:
NA
Brief Summary
Systemic autoimmune and chronic inflammatory diseases are a group of chronic illnesses whose treatment is usually very prolonged, often lifelong, and is essential to keep the disease under control, th...
Eligibility Criteria
Inclusion
- Any patient with one of the following conditions
- Rheumatoid Arthritis
- Psoriatic Arthritis
- Spondyloarthritis
- Ankylosing Spondylitis
- Systemic Sclerosis
- Systemic Lupus Erythematosus
- Sjogren's Disease who are prescribed a new immunosuppressive medication for the treatment of their disease among the following:
- Methotrexate
- Sulfasalazine
- Leflunomide
- Mycophenolate Mofetil
- Azathioprine
- Cyclosporine A
- Tacrolimus
- TNF inhibitors (etanercept, adalimumab, golimumab, certolizumab pegol)
- IL6 inhibitors (tocilizumab)
- IL-17 inhibitors (secukinumab, ixekizumab)
- IL-23 inhibitors (ustekinumab, guselkumab, risankizumab)
- JAK-inhibitors (tofacitinib, baricitinib, upadacitinib, filgotinib)
- Belimumab
- Anifrolumab
Exclusion
- Treatment with a medication not approved for the condition
- Inability to use a device for remote call, not even with the help of a caregiver
Key Trial Info
Start Date :
July 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 18 2026
Estimated Enrollment :
190 Patients enrolled
Trial Details
Trial ID
NCT06544343
Start Date
July 1 2024
End Date
March 18 2026
Last Update
August 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rheumatology Unit - Perugia Univeristy Hospital
Perugia, PG, Italy, 06129